Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2023 01:01 ET | Source: Ambu A/S

AMBU CAPITAL MARKETS DAY 2023

Ambu invites institutional investors, analysts and financial media to the company’s Capital Markets Day on Tuesday 21 March 2023. On 21 March 2023, Ambu will host its Capital Markets Day for...
February 07, 2023 01:00 ET | Source: Ambu A/S

INTERIM REPORT FOR Q1 2022/23

Ambu delivers solid performance for Q1 2022/23. The company posts 4% organic revenue growth for the quarter and continues to progress its new ZOOM IN strategy and global transformation program....
November 29, 2022 10:10 ET | Source: Ambu A/S

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu...
November 15, 2022 01:03 ET | Source: Ambu A/S

Annual Report 2021/22

Today, Ambu issues the Annual Report for the financial year 2021/22, including Sustainability Report and Remuneration Report. The reports can be found at Ambu.com. Attachments ...
November 15, 2022 01:01 ET | Source: Ambu A/S

ANNUAL RESULTS 2021/22 (EARNINGS RELEASE)

Ambu delivered 4% organic revenue growth for the year 2021/22. Global Endoscopy Solutions (previously named Visualisation) revenues grew organically by 1%, mainly driven by strong growth in the ENT...
September 30, 2022 08:15 ET | Source: Ambu A/S

Ambu A/S: Financial Calendar

This financial calendar lists the expected dates of publication of financial announcements and the Annual General Meeting for the financial year 2022/23. Please see attached PDF. CONTACTS ...
August 29, 2022 08:07 ET | Source: Ambu A/S

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu...
August 25, 2022 02:00 ET | Source: Ambu A/S

INTERIM REPORT FOR Q3 2021/22

Ambu delivered 8% organic revenue growth in Q3 with 5% organic growth year-to-date. This was driven by a continued rapid uptake of Ambu’s single-use endoscopes within urology and ENT, as well as...
August 03, 2022 15:15 ET | Source: Ambu A/S

Preliminary results for Q3 2021/22, current trading (July) and launch of cost reduction program. Full-year 2021/22 guidance revised

Preliminary Q3 organic revenue growth was 8%. Visualization organic growth was 0%, Anaesthesia organic growth was 14%, and Patient Monitoring & Diagnostics (PMD) organic growth was 20%.Current...
May 19, 2022 10:01 ET | Source: Ambu A/S

Britt Meelby Jensen appointed new CEO of Ambu

The Board of Directors of Ambu A/S has appointed Britt Meelby Jensen as new Chief Executive Officer (CEO). Britt Meelby Jensen has served as board member of Ambu since 2019, a position she will step...